Published 12 May 2009, doi:10.1136/bmj.b1916
Cite this as: BMJ 2009;338:b1916

Letters

Blood glucose in type 2 diabetes

Time to abolish QOF

The first 150 words of the full text of this article appear below.

Diabetes has become an industry, with a host of jobs ultimately dependent on the idea that intensive treatment will achieve better outcomes.1

I believe that many patients have been overtreated by doctors and nurses to hit the previous targets of the quality and outcomes framework (QOF). These patients have had severe hypoglycaemic episodes and gained a lot of weight (that they will probably never lose). In my experience, many obese patients starting insulin treatment will progress to morbid obesity, sleep apnoea syndrome, fatty liver disease, cirrhosis, severe osteoarthritis, and premature death. The new targets are a lot harder and will inevitably lead to more insulin, more hypoglycaemic episodes, more obesity.

That no QOF targets apply to specialist clinics is puzzling. If they did, I suspect that they would not be hit and the enthusiasm for the QOF would wane.

Observational studies do show a strong association between abnormal blood glucose . . . [Full text of this article]

Ted Willis, general practitioner1

1 Brigg, North Lincolnshire

ted.willis@nlpct.nhs.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Tight control of blood glucose in long standing type 2 diabetes
Richard Lehman and Harlan M Krumholz
BMJ 2009 338: b800. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ